AstraZeneca's Imfinzi shows promise in treating a form of advanced liver cancer

Delaware Business Now

Jan 20, 2022

Results from the a Phase III trial showed a single priming dose of tremelimumab added to AstraZeneca's Imfinzi demonstrated an improvement in overall survival for patients with the…